Sepsis 2025

The pandemic “goes away”, the real pandemic is here: Sepsis 2025

This important webinar highlights sepsis as a persistent and serious global health challenge, far outlasting the COVID-19 pandemic. Hosted jointly by ISAC and the European Sepsis Alliance to mark World Sepsis Day, the event features two expert-led lectures:

• Dr Ricard Ferrer will explore the role of biomarkers and molecular diagnostics in sepsis care, questioning their real-world impact on diagnosis and outcomes.

• Prof. Evangelos J. Giamarellos-Bourboulis will discuss the concept of holistic patient management, examining whether such an approach truly exists and how it can be implemented effectively.

Together, these sessions aim to spark critical dialogue and drive innovation in the global fight against sepsis.

Speaker bios

Evangelos J. Giamarellos-Bourboulis is Professor of Internal Medicine and Infectious Diseases at the Medical School of the National and Kapodistrian University of Athens and director of the MSc program of Infectious Diseases at the University of Athens. His main research contribution is immunomodulation in sepsis and in auto-inflammatory disorders. He has 571 publications in international peer-reviewed journals with more than 42,000 citations and h-index 94. He has contributed in the development of clarithromycin for immunomodulatory treatment of severe infections and in the recognition of hidradenitis suppurativa (HS) as an auto-inflammatory disorder and in the licensing of adalimumab for HS treatment. He is the current chairman of the European Sepsis Alliance and the current President of the Hellenic Society of Chemotherapy. His main achievement is the approval of anakinra for COVID-19 pneumonia in adults by the European Medicines Agency and the Food and Drug Administration through the phase 2 and 3 trials SAVE and SAVE-MORE that he designed and conducted.

Dr Ricard Ferrer is Head of the Intensive Care Department at Vall d’Hebron Hospital in Barcelona, Spain. He graduated in 1992 from the University of Barcelona, Medical School and pursued his specialisation in Intensive Care from 1994 to 1998 and his PhD title in 2010 from the Universitat Autonoma de Barcelona.

Dr Ferrer is the Head of the SODIR research group at Vall d’Hebron Institute of research and collaborates is several research networks: CIBERES, EDUSEPSIS and EGIS. He has published a number of original articles and review articles in peer reviewed journal in the field of sepsis and severe infections and has contributed to the publication of book chapters on those topics (H-index Google Scholar 2024= 66).

Regarding teaching activities, Dr. Ferrer is Associate Professor at Universitat Autònoma de Barcelona and Co-director of Severe Infections and sepsis Masterclass at ESICM.

Prof. Ferrer holds several positions at a numerous intensive care societies: He is past-president of the Spanish Society of Intensive Care (SEMICYUC), Treasurer of European Society of Intensive Care (ESICM), member of the Council of the World Federation of Intensive Care Societies (WFICC) and Patron of the Foundation Codigo Sepsis.

MODERATORS:

Michael David (ISAC Executive Committee), University of Pennsylvania, USA

Sabiha Essask (ISAC Executive Committee), University of KwaZulu-Natal, South Africa